ALVAL.PA
Price:
$0.708
Market Cap:
$16.75M
Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
Industry
Biotechnology
IPO Date
2017-06-07
Stock Exchange
PAR
Ticker
ALVAL.PA
According to Valbiotis S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -1.01. This represents a change of -65.77% compared to the average of -2.95 of the last 4 quarters.
The mean historical PE Ratio of Valbiotis S.A. over the last ten years is -10.41. The current -1.01 PE Ratio has changed 870.44% with respect to the historical average. Over the past ten years (40 quarters), ALVAL.PA's PE Ratio was at its highest in in the December 2024 quarter at -0.92. The PE Ratio was at its lowest in in the December 2015 quarter at -57.60.
Average
-10.41
Median
-4.92
Minimum
-59.83
Maximum
-0.16
Discovering the peaks and valleys of Valbiotis S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 36.56%
Maximum Annual PE Ratio = -0.16
Minimum Annual Increase = -88.49%
Minimum Annual PE Ratio = -59.83
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.39 | -71.68% |
| 2023 | -8.46 | 185.94% |
| 2022 | -2.96 | -59.07% |
| 2021 | -7.23 | -38.74% |
| 2020 | -11.80 | 516.88% |
| 2019 | -1.91 | -22.01% |
| 2018 | -2.45 | -64.41% |
| 2017 | -6.89 | -88.49% |
| 2016 | -59.83 | 36.56% |
The current PE Ratio of Valbiotis S.A. (ALVAL.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.60
5-year avg
-6.57
10-year avg
-10.41
Valbiotis S.A.’s PE Ratio is greater than Aelis Farma S.A. (-1.79), less than Poxel S.A. (-0.26), greater than NFL Biosciences S.A. (-5.29), less than GenSight Biologics S.A. (-0.80), greater than Intrasense S.A. (-2.08), less than TME Pharma N.V. (-0.33), greater than THX Pharma (-7.83), less than Plant Advanced Technologies S.A. (10.44), less than Nicox S.A. (-0.68), less than Biosynex S.A. (-0.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.79 | $14.64M | |
| -0.26 | $12.46M | |
| -5.29 | $14.19M | |
| -0.80 | $19.65M | |
| -2.08 | $13.48M | |
| -0.33 | $6.55M | |
| -7.83 | $17.33M | |
| 10.44 | $9.80M | |
| -0.68 | $24.60M | |
| -0.14 | $8.77M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valbiotis S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Valbiotis S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Valbiotis S.A.'s PE Ratio?
How is the PE Ratio calculated for Valbiotis S.A. (ALVAL.PA)?
What is the highest PE Ratio for Valbiotis S.A. (ALVAL.PA)?
What is the 3-year average PE Ratio for Valbiotis S.A. (ALVAL.PA)?
What is the 5-year average PE Ratio for Valbiotis S.A. (ALVAL.PA)?
How does the current PE Ratio for Valbiotis S.A. (ALVAL.PA) compare to its historical average?